Hybrid Conferencee

International Conference on Molecular Oncology and Immunology (ICMOI - 27)

2nd - 3rd April 2027 | Teresina, Brazil
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Teresina. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Teresina event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Teresina conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Teresina, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Teresina."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Molecular Oncology

This track will explore the latest breakthroughs in molecular oncology, focusing on the genetic and epigenetic factors that influence cancer development. Researchers are invited to present novel findings that enhance our understanding of tumor biology and therapeutic targets.

Track 02

Immunotherapy Strategies in Cancer Treatment

This session will delve into innovative immunotherapeutic approaches for cancer management, including checkpoint inhibitors and CAR T-cell therapy. Contributions that discuss clinical outcomes and mechanisms of action are particularly encouraged.

Track 03

Epidemiological Trends in Cancer Incidence

This track aims to highlight recent epidemiological studies that identify trends and risk factors associated with cancer incidence across diverse populations. Presentations will focus on data analysis and implications for public health initiatives.

Track 04

Tumor Microenvironment and Immune Response

This session will investigate the interactions between tumor cells and the immune microenvironment, emphasizing how these relationships influence cancer progression and treatment response. Researchers are invited to present studies that elucidate these complex dynamics.

Track 05

Biomarkers in Oncology: Discovery and Application

This track will focus on the identification and validation of biomarkers for cancer diagnosis, prognosis, and treatment response. Submissions that discuss both laboratory and clinical applications of biomarkers are welcome.

Track 06

Cancer Prevention and Control Strategies

This session will address effective strategies for cancer prevention and control, including lifestyle interventions and screening programs. Contributions that evaluate the impact of these strategies on population health are encouraged.

Track 07

Innovations in Cancer Genomics

This track will explore cutting-edge genomic technologies and their applications in oncology, including next-generation sequencing and personalized medicine. Researchers are invited to share insights into how genomic data can inform treatment decisions.

Track 08

The Role of the Immune System in Cancer Progression

This session will examine the dual role of the immune system in cancer progression and suppression, highlighting recent discoveries in immune evasion mechanisms. Presentations that explore therapeutic implications of these findings are encouraged.

Track 09

Clinical Trials in Oncology: Challenges and Innovations

This track will discuss the design, implementation, and outcomes of clinical trials in oncology, addressing both challenges and innovative solutions. Contributions that highlight patient-centered approaches and novel trial designs are particularly welcome.

Track 10

Translational Research in Immunology

This session will focus on the translation of basic immunological research into clinical applications for cancer treatment. Researchers are invited to present studies that bridge the gap between laboratory findings and therapeutic interventions.

Track 11

Global Health Perspectives in Cancer Epidemiology

This track will explore the global burden of cancer and the epidemiological factors that contribute to disparities in cancer outcomes. Presentations that address international collaborations and public health policies are encouraged.